Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

And the market for insulin has changed fast. Since 2023, drug companies have cut costs voluntarily, spurred by government ...

In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or ...

Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.

High-deductible health insurance plans are increasingly common, and many more enrollees will likely need to choose such plans ...

Infections, droopy eyelids, actual botulism — is saving a few dollars really worth all that risk? For some, the answer is ‘yes.' ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long as his A1C and cholesterol numbers stay within the normal range. Turner is ...

Constitutional role of Congress: The framers gave the Congress the power to appropriate funds, to declare war and levy taxes, ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...

Peptide can signal collagen to rebuild, inflammation to ease, muscle recovery to accelerate or hormones to regulate.

Innovation and patient safety have always been the cornerstones of the pharmaceutical industry. Today, much of this innovation comes in the form of complex drug formulations and smarter aseptic ...